Personalis to Participate at Upcoming Investor Conferences

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will participate at the following investor conferences:

• Morgan Stanley 22nd Annual Global Healthcare Conference
  Date: Thursday, September 5, 2024
  Presentation Time: 4:50 pm Eastern Time
  Location: Marriott Marquis in New York
  

• Lake Street 8th Annual Best Ideas Growth (BIG) Conference
  Date: Thursday, September 12, 2024
  Location: Yale Club in New York

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest time points, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240822337911/en/

Investors:
Caroline Corner
[email protected]
415-202-5678

Media:
[email protected]

Source: Personalis, Inc.

You May Also Be Interested In

• I Squared Capital to Sell Minority Stake in TIP Group, a Leading Pan-European Equipment Leasing Platform, to IMCO and GCM Grosvenor
• Ghana's First Precision Medicine Company Completes German Development Grant Programme, Delivering Measurable Impact Across Patient Access, Diagnostic Innovation, and Clean Energy
• RWS launches new linguistic validation service to significantly reduce clinical trial timelines